Video

Being Open About Mental Health Care During Cancer Treatment

Author(s):

To combat the stigma around mental health care for patients with lung cancer, survivor Nancy Cohen shares her own treatment story and why she feels it's important to include mental health care during cancer treatment.

Patients go through many emotions after receiving a cancer diagnosis, especially those with lung cancer who face stigma associated with the disease, such as smoking led to their diagnosis. Stigmas like this can cause mental health distress for which patients may not seek support, according to Nancy Cohen, a lung cancer survivor turned patient advocate, who uses her voice to help others with the disease.

Cohen recently served as the keynote speaker during the CURE® Patient-Focused Sessions at the New York Lung Cancers Symposium® on Nov. 9 addressing a crowd of more than 80 patients with lung cancer. She shared her story to highlight that there is more to the treatment journey than just taking medication and going for routine visits. In an interview with CURE®, her address focused on how mental health care is just as important and shouldn’t be overlooked.

Transcription:

The other thing that is important is managing the mental health aspect of it. I started working with a therapist who specializes in oncology patients. And, I think, we can talk about the stigma of lung cancer and the stigma of mental health and sort of making sure that neither of those is present because I think, you know, going through this is hard enough. And, going through it with a mental health professional is so important.

Related Videos
Image of Dr. Fakih.
.Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
Image of Doctor with blonde hair.
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma who have diabetes.
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Dr. Neeraj Agarwal is a medical oncologist, a professor of medicine and the Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah, as well as director of the Genitourinary Oncology Program and the Center of Investigational Therapeutics at the Huntsman Cancer Institute in Salt Lake City.
Image of Dr. Goy.
Image of bald man.